Timing of response in patients with relapsed/refractory FLT3 mut+ acute myeloid leukemia treated with gilteritinib.

Xospata (gilteritinib) - Astellas

http://www.ncbi.nlm.nih.gov/pubmed/42668697

Alexander E Perl; Andrew H Wei; Dina Elsouda; Hee-Je Kim; Hisayuki Yokoyama; Jamie Jung-Hee An; Jian Li; Jianxiang Wang; Juan Ariza; June-Won Cheong; Mark J Levis; Nahla Hasabou; Naoko Hosono; Sergey Bondarenko

Aug 31, 2026